New User:

Forgot your password?

Stock Market & Financial Investment News

News For NVS;MOS;SCCO;ADM;IP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | all recent news | >>
May 4, 2015
15:01 EDTADMNotable companies reporting before tomorrow's open
Subscribe for More Information
07:35 EDTNVSNewYorkBio to hold a conference
Subscribe for More Information
May 1, 2015
15:14 EDTNVSExpress Scripts in settlement pact related to alleged Novartis kickbacks
Accredo Health, a wholly-owned subsidiary of Express Scripts (ESRX), entered a settlement and dismissal agreement with United States Attorney for the Southern District of New York, Preet Bharara, related to Accredo's alleged involvement in Novartis's (NVS) alleged participation in a kickback scheme involving Exjade, according to a court filing. In settlement of the United States' claims against Accredo in this action, Accredo shall pay to the United States a sum just over $45M, according to the court filing. A recent filing with the SEC noted that a total of $60M was set aside by Express Scripts to resolve the allegations with the federal government and all 50 states and a company spokesman confirmed the settlement involves $60M, according to The Wall Street Journal. Reference Link
10:00 EDTMOSOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: CVR Refining (CVRR) upgraded to Neutral from Underperform at Credit Suisse... Cash America (CSH) upgraded to Outperform from Market Perform at JMP Securities... Chipotle (CMG) upgraded on positive catalysts at BMO Capital... Cypress Semiconductor (CY) upgraded to Strong Buy from Buy at Needham... Energy Transfer Equity (ETE) upgraded to Strong Buy from Outperform at Raymond James... Expedia (EXPE) upgraded to Outperform from Sector Perform at RBC Capital... Immersion (IMMR) upgraded to Buy from Hold at Ascendiant... Integra LifeSciences (IART) upgraded to Outperform from Market Perform at Wells Fargo... Key Energy (KEG) upgraded to Neutral from Reduce at Global Hunter... Limelight Networks (LLNW) upgraded to Buy from Neutral at B. Riley... Live Nation (LYV) upgraded followin strong core results at Stifel... Mosaic (MOS) upgraded to Outperform from Sector Perform at RBC Capital... Ocwen (OCN) upgraded to Buy from Neutral at Sterne Agee CRT... Pacific Biosciences (PACB) upgraded to Outperform from Market Perform at William Blair... Pinnacle Financial (PNFP) upgraded to Buy from Hold at Sandler O'Neill... SPX Corp. (SPW) upgraded to Overweight from Neutral at JPMorgan... Titan International (TWI) upgraded to Buy from Hold at Feltl... Ultra Petroleum (UPL) upgraded to Market Perform from Underperform at Raymond James... United Insurance (UIHC) upgraded to Outperform from Market Perform at Keefe Bruyette... Western Union (WU) upgraded to Outperform from Market Perform at Wells Fargo... Zayo Group (ZAYO) upgraded to Strong Buy from Outperform at Raymond James.
09:26 EDTMOSPotash, Mosaic investors should switch to Agrium, says Canaccord
Canaccord noted that both Potash (POT) and Mosaic (MOS) missed Q1 estimates and gave what the firm views as soft forward guidance. The firm sees U.S. shipments of potash and phosphates this spring lower than expected and sees international volumes heading into a mild oversupply situation. Canaccord suggests Potash and Moasic investors switch into Agrium (AGU), given its exposure to nitrogen and retail segments. Canaccord maintains its Buy rating and lowered its price target to $125 from $128 on Agrium, while maintaining its Hold rating on both Potash and Mosaic shares.
07:59 EDTMOSMosaic upgraded to Outperform from Sector Perform at RBC Capital
Subscribe for More Information
07:43 EDTNVSExpensive drugs drove over 25% of 2013 Medicare drug spending, WSJ says
Subscribe for More Information
April 30, 2015
06:23 EDTMOSMosaic sees Q2 Phosphates sales volumes 2.3M-2.7M tonnes
Subscribe for More Information
06:20 EDTMOSMosaic reports Q1 EPS 80c, consensus 74c
Subscribe for More Information
April 29, 2015
13:20 EDTMOSEarnings Watch: Potash sees Q1 EPS 45c-55c per share
Subscribe for More Information
10:53 EDTMOSMosaic May volatility elevated into Q1 and outlook
Subscribe for More Information
09:30 EDTSCCOSouthern Copper downgraded to Neutral from Buy at Citigroup
Subscribe for More Information
07:03 EDTIPInternational Paper reports Q1 Industrial Packaging operating profit $468M
Reports Q1 Printing Papers operating profit $109M. Reports Q1 Consumer Packaging operating profits $46M.
07:03 EDTIPInternational Paper reports Q1 operating EPS 84c, consensus 80c
Reports Q1 revenue $5.52B, consensus $5.8B.Business segment operating profits before special items in the first quarter of 2015 were $623M.
April 28, 2015
15:07 EDTIPNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's open, with earnings consensus, include MasterCard (MA), consensus 80c... Time Warner (TWX), consensus $1.09... Mondelez (MDLZ), consensus 38c... NextEra Energy (NEE), consensus $1.27... General Dynamics (GD), consensus $1.95... Lumber Liquidators (LL), consensus 16c... Southern Co (SO), consensus 58c... Anthem (ANTM), consensus $2.66... Praxair (PX), consensus $1.44... Norfolk Southern (NSC), consensus $1.00... Eaton (ETN), consensus 98c... Thomson Reuters (TRI), consensus 45c... Franklin Resources (BEN), consensus 86c... Northrop Grumman (NOC), consensus $2.27... Hilton Worldwide (HLT), consensus 12c... Exelon (EXC), consensus 69c... Humana (HUM), consensus $2.56... International Paper (IP), consensus 80c... Hess (HES), consensus ($1.05)... Level 3 Communications (LVLT), consensus 33c... Starwood Hotels & Resorts (HOT), consensus 57c... Ametek (AME), consensus 63c... Garmin (GRMN), consensus 57c... Quintiles Transnational (Q), consensus 71c... New York Community Bancorp (NYCB), consensus 26c... Spirit Aerosystems (SPR), consensus 92c... Spirit Airlines (SAVE), consensus 96c... Brunswick (BC), consensus 61c... KBR (KBR), consensus 17c... Linn Energy (LINE), consensus (20c)... Cullen/Frost Bankers (CFR), consensus $1.09... WEX (WEX), consensus 99c... RPC (RES), consensus 11c... Hercules Offshore (HERO), consensus (38c).
April 27, 2015
11:02 EDTADMArcher Daniels invests in North Dakota plant to increase processing flexibility
Subscribe for More Information
10:30 EDTNVSNovartis says Phase III Arzerra study met primary endpoint
Subscribe for More Information
06:19 EDTNVSPharmceutical companies buy drugs and raises prices, WSJ reports
Subscribe for More Information
April 24, 2015
13:34 EDTSCCOSouthern Copper reports Q1 EPS 35c, consensus 28c
Reports Q1 revenue $1.27B, consensus $1.36B. Copper production in 1Q15 increased 8.9% to 177,616 tons from 163,168 tons in 1Q14. Molybdenum production increased 5.2% to 5,856 tons in 1Q15 from 5,564 tons in 1Q14.
April 23, 2015
09:52 EDTNVSEli Lilly sees at least $200M in savings from Novartis Animal Health acquisition
05:25 EDTNVSNovartis backs FY15 revenue guidance of growth in mid-single digits
Subscribe for More Information
05:22 EDTNVSNovartis reports Q1 Core EPS $1.33, consensus $1.10
Subscribe for More Information
April 22, 2015
05:50 EDTIPStocks with implied volatility movement; CMG IP
Stocks with implied volatility movement; Chipotle (CMG) 37, International Paper (IP) 28 according to iVolatility.
April 21, 2015
05:29 EDTADMArcher Daniels acquisition of facilities in Bulgaria, Turkey
Subscribe for More Information
05:26 EDTNVSNovartis says data shows Gilenya high efficacy
Novartis announced new analysis from the Phase III FREEDOMS and FREEDOMS II. The data showed that previously-treated patients with highly-active relapsing multiple sclerosis, or RMS, who were treated with Gilenya had a six-times greater likelihood of achieving 'no evidence of disease activity' across four key measures of disease activity compared to placebo over two years. This is referred to as NEDA4 and is achieved when a patient with RMS has no relapses, no new MRI lesions, no MS-related brain shrinkage and no disability progression. This analysis was the first time patients with highly-active RMS who had been treated in the previous year with an injectable therapy were assessed using the NEDA4 definition that includes brain shrinkage. Brain shrinkage is a marker of the widespread inflammatory damage in the central nervous system and is associated with accumulated loss of function. By using this updated NEDA4 definition, physicians are able to get a more complete picture of a patient's disease and response to treatment, which is crucial to identify the optimal therapy to slow short- and long-term disease progression. This is especially important for people with highly-active RMS, who are at a greater risk of relapses and future loss of function, and may therefore require a different treatment approach.
<< 1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use